| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 103 | 4.001 | 3.015 | 3.681 | 3.368 | 5.078 | 2.288 |
| Total Income - EUR | - | - | - | 103 | 4.001 | 3.015 | 3.681 | 3.368 | 5.078 | 2.288 |
| Total Expenses - EUR | - | - | - | 1.761 | 2.333 | 2.180 | 3.043 | 3.332 | 3.269 | 1.712 |
| Gross Profit/Loss - EUR | - | - | - | -1.658 | 1.669 | 834 | 638 | 35 | 1.809 | 576 |
| Net Profit/Loss - EUR | - | - | - | -1.658 | 1.548 | 750 | 556 | 35 | 1.520 | 487 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Kleovetmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 865 | 717 | 585 | 1.110 | 762 | 579 | 395 |
| Current Assets | - | - | - | 424 | 893 | 1.458 | 1.476 | 1.222 | 2.377 | 3.989 |
| Inventories | - | - | - | 381 | 822 | 1.425 | 1.475 | 1.213 | 900 | 1.408 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 7 | 1.367 | 1.379 |
| Cash | - | - | - | 43 | 72 | 33 | 0 | 1 | 110 | 1.202 |
| Shareholders Funds | - | - | - | -1.615 | -35 | 716 | 1.256 | 1.296 | 2.811 | 3.282 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.904 | 1.646 | 1.328 | 1.329 | 732 | 144 | 1.102 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Kleovetmed S.r.l.